OMRON Healthcare Co., Ltd. has announced a renewed wave of investment in Tricog Health India Pvt. Ltd., strengthening a partnership that is rapidly reshaping how cardiovascular disease is diagnosed, monitored, and managed across India. This marks OMRON’s second strategic investment in the AI MedTech company, following the initial infusion made in March 2023.

India today faces a cardiac health challenge of unprecedented scale. According to WHO estimates, cardiovascular and cerebrovascular diseases are the top two causes of death in the country, driven by lifestyle changes, rising comorbidities, and an aging population. Yet, even as the burden rises, India struggles with a severe shortage of certified cardiologists compared to countries like Japan and the United States. Many healthcare facilities also lack advanced ECG equipment, creating critical diagnostic delays.

It is in this context that Tricog Health has emerged as a transformative force. The company blends over a decade of ECG data, advanced AI algorithms, and the expertise of more than 100 in-house clinical specialists to deliver rapid, accurate cardiac analysis across frontline clinical settings. Its AI–human hybrid model is designed to support hospitals, clinics, and remote-care environments with equal efficiency.

Speaking on the strategic significance of the collaboration, Dr. Charit Bhograj, CEO of Tricog Health, said:
“Together, we will accelerate a hospital-to-home rollout, pairing OMRON’s world-class medical devices with Keebo™ AI-powered, guideline-aware workflows. This will streamline diagnosis, improve cardiovascular management, and reduce avoidable healthcare costs across Asia, Africa and other key international markets.”

One of the strongest results of this partnership is the launch of KeeboHealth, a remote monitoring service for heart-failure patients introduced in 2023. The platform combines OMRON’s connected ECG and blood pressure devices with Tricog’s AI-enabled analytics to monitor patients at home. Physicians receive real-time trends and alerts, enabling timely intervention and reducing the likelihood of post-treatment recurrence—a major cause of readmissions in India’s cardiac population.

The expanded investment will allow OMRON and Tricog to scale these capabilities further, especially as India transitions toward continuous, preventive cardiac care rather than episodic treatment. The collaboration will also support the development of new device–software models tailored to Indian clinical needs and adaptable to international markets.

Reflecting on India’s critical moment in cardiovascular health, Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd., noted:
“India is at a pivotal moment when it comes to facing cardiovascular disease, and we are proud to deepen our partnership with Tricog Health to bring advanced remote patient monitoring services and early detection to patients nationwide. Combining Tricog’s AI-driven cardiology platform with OMRON’s medical technology will improve outcomes, reduce risk and bring us closer to our global vision of ‘Going for ZERO’ cardiovascular events.”

OMRON’s global mission, “Going for ZERO,” centers on creating a world where preventable cardiovascular and cerebrovascular events no longer occur. The company considers strategic collaborations essential to accelerating progress—and sees Tricog as a key technology partner in that journey.

With this latest investment, OMRON Healthcare reaffirms its commitment not only to India but also to the broader global shift toward AI-enabled, patient-centered cardiovascular care. Together, OMRON and Tricog aim to create scalable, cost-effective solutions that bring early detection, remote monitoring, and guideline-based clinical workflows to millions—transforming cardiac care from hospital corridors to patient homes.